insights_auto
Kāpēc uzņēmuma AMG akciju cena ir pieaugusi 2,25%?
Atklājiet vairāk iespējuchevron_right
AMG:ETR
Amgen Inc
425,45 €
arrow_upward
+2,25%(+9,35) 1 d.
12. nov., 17:35:48 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: AMG…
Atvērt
426,45 €
Augsta
427,20 €
Zema
420,90 €
Tirgus kapitalizācija
252,64 mljrd.
Vid. apjoms
555,00
Apjoms
568,00
Augstākā 52 ned.
438,75 €
Zemākā 52 ned.
267,60 €
Darbinieku skaits
32 tūkst.
Atvērt
426,45 €
Augsta
427,20 €
Zema
420,90 €
Tirgus kapitalizācija
252,64 mljrd.
Vid. apjoms
555,00
Apjoms
568,00
Augstākā 52 ned.
438,75 €
Zemākā 52 ned.
267,60 €
Darbinieku skaits
32 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Trefis
·
pirms 3 stundām
Is Amgen Stock Priced Right Against Its Peers?
Investing.com
·
pirms 8 stundām
Argus raises Amgen stock price target on pipeline strength
Yahoo Finance
·
pirms 9 stundām
Amgen Inc. (AMGN) Stock Forecasts
TradingView
·
pirms 10 stundām
TScan Therapeutics Q3 revenue drops after Amgen collaboration ends
Profils
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Par “Amgen Inc”
ĢenerāldirektorsRobert A. Bradway
Darbinieki31,5 tūkst.
Dibināšanas datums1980
Galvenais birojsTauzandoksa, Kalifornija, Amerikas Savienotās Valstis
SektorsHealth Care
Nozare-
Tīmekļa vietneamgen.com